Back to resultsDavallia Divaricata BL: The Use of Traditional Chinese Native Medicine for Osteoporosis
Primary Purpose
Osteoporosis
Status
Unknown status
Phase
Phase 1
Locations
Taiwan
Study Type
Interventional
Intervention
Gu-Sui-Bu (Davallia Divaricata)
Sponsored by
About this trial
This is an interventional treatment trial for Osteoporosis
Eligibility Criteria
Inclusion Criteria: Postmenopausal osteoporosis Exclusion Criteria: Insulin dependent diabetes
Sites / Locations
- National Taiwan University Medical CenterRecruiting
Outcomes
Primary Outcome Measures
The project is aimed to investigate the clinical effects of the water extract of Gu-Sui-Bu from the aspects of animal and clinic studies.
Secondary Outcome Measures
Full Information
NCT ID
NCT00154609
First Posted
September 9, 2005
Last Updated
January 20, 2006
Sponsor
National Taiwan University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT00154609
Brief Title
Davallia Divaricata BL: The Use of Traditional Chinese Native Medicine for Osteoporosis
Official Title
The Use Tradition Chinese Native Medicine Treats the Osteoporosis Research
Study Type
Interventional
2. Study Status
Record Verification Date
January 2002
Overall Recruitment Status
Unknown status
Study Start Date
January 2002 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
National Taiwan University Hospital
4. Oversight
5. Study Description
Brief Summary
We, the investigators at National Taiwan University Hospital, have determined the therapeutic and toxic effects of the traditional herb on the ovariectomized Wistar rat.
The final years will determine its effects on the therapy of women who are over 45 years old and postmenopausal with osteoporosis.
Detailed Description
Research of this traditional chinese clinical medicine, Gusuibu, curative effect is planned for three years time. The entire study aims to evaluate the effect of the traditional chinese medicine on postmenopausal osteoporosis as well as the possible side effects on the experimental animal and the human body. All subjects were postmenopausal women with established osteoporosis.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoporosis
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 1
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
Enrollment
100 (false)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Gu-Sui-Bu (Davallia Divaricata)
Primary Outcome Measure Information:
Title
The project is aimed to investigate the clinical effects of the water extract of Gu-Sui-Bu from the aspects of animal and clinic studies.
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
45 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Postmenopausal osteoporosis
Exclusion Criteria:
Insulin dependent diabetes
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Liu Hwa-Chang, Ph.D
Phone
886-2-23956988
Email
hcliu@ha.mc.ntu.edu.tw
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Liu Hwa-Chang, Ph.D
Organizational Affiliation
National Taiwan University Medical Center
Official's Role
Study Chair
Facility Information:
Facility Name
National Taiwan University Medical Center
City
Taipei
State/Province
7, Chung-Shan South Road
ZIP/Postal Code
100
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Liu Hwa-Chang, Ph.D
Phone
886-2-23956988
Email
hcliu@ha.mc.ntu.edu.tw
12. IPD Sharing Statement
Learn more about this trial
Davallia Divaricata BL: The Use of Traditional Chinese Native Medicine for Osteoporosis
We'll reach out to this number within 24 hrs